CXCL13 and neoplasm: This study was pioneering in conducting a Pan-Gyn analysis based on CXCL13 expression and revealed that CXCL13 can serve as a prognostic factor, concurrently playing a pivotal role in TIME by influencing tumor-infiltrating immune cells and apoptotic pathways.